FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Franco Rovelli

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Luigi Vigoré; Giusy Messina; Fernando Brivio; Luca Fumagalli; Franco Rovelli; Giuseppe DI Fede; Paolo Lissoni
Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
Fernando Brivio; Luca Fumagalli; Gabriele Fumagalli; Simonetta Pescia; Rinaldo Brivio; Giuseppe Di Fede; Franco Rovelli; Paolo Lissoni
Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.
Paolo Lissoni; Giusy Messina; Franco Rovelli; Fernando Brivio; Luca Fumagalli; Sara Villa; Erio Bartolacelli
HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Franco Rovelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Luigi Vigoré; Giusy Messina; Fernando Brivio; Luca Fumagalli; Franco Rovelli; Giuseppe DI Fede; Paolo Lissoni
Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
In vivo (Athens, Greece) 2010;24(5):787-9.
2010: Fernando Brivio; Luca Fumagalli; Gabriele Fumagalli; Simonetta Pescia; Rinaldo Brivio; Giuseppe Di Fede; Franco Rovelli; Paolo Lissoni
Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.
In vivo (Athens, Greece) 2010;24(2):239-41.
2009: Paolo Lissoni; Giusy Messina; Franco Rovelli; Fernando Brivio; Luca Fumagalli; Sara Villa; Erio Bartolacelli
HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
In vivo (Athens, Greece) 2009;23(6):987-9.
2009: Paolo Lissoni; Fernando Brivio; Luca Fumagalli; Giusy Messina; S Meregalli; G Porro; Franco Rovelli; L Vigorè; E Tisi; G D'Amico
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
Anticancer research 2009;29(5):1847-52.
2008: Paolo Lissoni; Giusy Messina; D Parolini; A Balestra; Fernando Brivio; Luca Fumagalli; L Vigore; Franco Rovelli
A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patients.
In vivo (Athens, Greece) 2008;22(5):577-81.
2008: Paolo Lissoni; Franco Rovelli; Fernando Brivio; Luca Fumagalli; G Brera
A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
In vivo (Athens, Greece) 2008;22(3):397-400.
2008: Paolo Lissoni; Fernando Brivio; Luca Fumagalli; Giusy Messina; Luigi Vigoré; Daniela Parolini; Massimo Colciago; Franco Rovelli
Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
Anticancer research 2008;28(2B):1377-81.
2007: Paolo Lissoni; Fernando Brivio; Luca Fumagalli; Giusy Messina; G Secreto; B Romelli; Gabriele Fumagalli; Franco Rovelli; Massimo Colciago; G Brera
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
In vivo (Athens, Greece) 2007;21(4):647-50.
2006: Paolo Lissoni; Luca Fumagalli; Fernando Brivio; Franco Rovelli; Giusy Messina; G Di Fede; Massimo Colciago; G Brera
Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.
Journal of biological regulators and homeostatic agents 2006;20(1-2):29-35.
2005: Paolo Lissoni; Giusy Messina; Fernando Brivio; Franco Rovelli; G Di Fede; E Mainini; E Veronese
Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
Journal of biological regulators and homeostatic agents 2005;19(3-4):141-4.
2004: Paolo Lissoni; Maristella Perego; Elisabetta Veronese; Gabriele Fumagalli; Fernando Brivio; Massimo Colciago; Giusy Messina; Franco Rovelli; Rinaldo Brivio; Gianstefano Gardani
Endocrine effects of erythropoietin in cancer patients.
Hematology (Amsterdam, Netherlands) 2004;9(5-6):363-7.
2004: Paolo Lissoni; MM Vaghi; S Pescia; Franco Rovelli; A Ardizzola; F Valtulina; Fabio Malugani; Gianstefano Gardani; Gabriele Tancini
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia.
Journal of biological regulators and homeostatic agents 2004;18(3-4):291-4.
2003: Paolo Lissoni; Giusy Messina; MM Vaghi; Erio Bartolacelli; L L Massarenti; P Trabattoni; P Meregalli; M Meregalli; C Gavazzeni; Franco Rovelli; Gabriele Tancini; Gianstefano Gardani
A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patients.
In vivo (Athens, Greece) 2003;17(6):647-50.
2003: P Lissoni; Franco Rovelli; Fabio Malugani; Fernando Brivio; L Fumagalli; Gianstefano Gardani
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer.
The International journal of biological markers 2003;18(2):152-5.
2003: Claudio Franciosi; Maria Gaia Piacentini; Matteo Conti; Fabrizio Romano; Flavia Musco; Roberto Caprotti; Franco Rovelli; Franco Uggeri
IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
Hepato-gastroenterology 2003;50(49):297-300.
2002: Claudio Franciosi; Andrea Ferrari Bravo; Fabrizio Romano; Luca Fumagalli; Katia Cerea; Matteo Conti; Franco Rovelli; Franco Uggeri
Immunodeficiency in radically operable gastric cancer patients.
Hepato-gastroenterology 2002;49(45):857-9.
2002: Fernando Brivio; Paolo Lissoni; Franco Rovelli; Angelo Nespoli; Franco Uggeri; Luca Fumagalli; Gianstefano Gardani
Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
Hepato-gastroenterology 2002;49(44):385-7.
2001: Paolo Lissoni; P Cangemi; D Pirato; maria grazia roselli; Franco Rovelli; Fernando Brivio; Fabio Malugani; Georges Maestroni; Ario Conti; Moshe Laudon; O Malysheva; Luisa Giani
A review on cancer--psychospiritual status interactions.
Neuro endocrinology letters 2001;22(3):175-80.
2001: Paolo Lissoni; Fabio Malugani; A Bonfanti; R Bucovec; S Secondino; Fernando Brivio; A Ferrari-Bravo; R Ferrante; L Vigoré; Franco Rovelli; Mario Mandalà; Simonetta Viviani; Luca Fumagalli; Gianstefano Gardani
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Journal of biological regulators and homeostatic agents 2001;15(2):140-4.
2001: Paolo Lissoni; Franco Rovelli; D Vellani; Fabio Malugani; R Bucovec; L Chapovalenko; Elena Fumagalli; Gianstefano Gardani
Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer.
The International journal of biological markers 2001;16(2):146-7.
2001: D Viganò; Paolo Lissoni; Franco Rovelli; maria grazia roselli; Fabio Malugani; C Gavazzeni; Ario Conti; Georges Maestroni
A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.
Neuro endocrinology letters 2001;22(2):137-41.
2001: Paolo Lissoni; R Bucovec; A Bonfanti; Luisa Giani; A Mandelli; maria grazia roselli; Franco Rovelli; Luca Fumagalli
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia.
Journal of pineal research 2001;30(2):123-6.
2001: Paolo Lissoni; Franco Rovelli; Fabio Malugani; R Bucovec; Ario Conti; Georges Maestroni
Anti-angiogenic activity of melatonin in advanced cancer patients.
Neuro endocrinology letters 2001;22(1):45-7.
2001: Paolo Lissoni; Franco Rovelli; N Baiocco; G Tangini; Luca Fumagalli
A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone.
Anticancer research 2001;21(1B):777-9.
2000: Paolo Lissoni; Fernando Brivio; Franco Rovelli; Gabriele Fumagalli; Fabio Malugani; MM Vaghi; S Secondino; R Bucovec; Gianstefano Gardani
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
Journal of biological regulators and homeostatic agents 2000;14(4):275-7.
2000: Paolo Lissoni; Mario Mandalà; Franco Rovelli; M Casu; Francesco Rocco; Gabriele Tancini; Epifanio Scardino
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
European urology 2000;37(5):569-72.
2000: A Bonfanti; Paolo Lissoni; R Bucovec; Franco Rovelli; Fernando Brivio; Luca Fumagalli
Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer.
The International journal of biological markers 2000;15(2):161-4.
1999: Mario Mandalà; Paolo Lissoni; Antonio Ardizzoia; S Barni; Franco Rovelli; G Confalonieri; Fabio Malugani; C Moro; Gabriele Fumagalli; Luisa Giani; Gabriele Tancini
Endocrinological study of the dopaminergic regulation of prolactin release in metastatic breast cancer.
Tumori 1999;85(6):494-7.
1999: Luca Fumagalli; Paolo Lissoni; G Di Felice; S Meregalli; G Valsuani; Susan Mengo; Franco Rovelli
Pretreatment serum markers and lymphocyte response to interleukin-2 therapy.
British journal of cancer 1999;80(3-4):407-11.
1999: Paolo Lissoni; Franco Rovelli; S Pittalis; M Casati; Luisa Giani; S Barni; Luca Fumagalli; Moshe Laudon
[Therapy with melatonin does not suppress its endogenous production in healthy volunteers].
Recenti progressi in medicina 1999;90(2):84-5.
1998: Paolo Lissoni; Franco Rovelli; Mario Mandalà; S Barni
Blood concentrations of interleukin-15 in cancer patients and their variations during interleukin-2 immunotherapy: preliminary considerations.
The International journal of biological markers 1998;13(3):169-71.
1998: Paolo Lissoni; Franco Rovelli; Luisa Giani; mario mandala; S Meregalli; S Barni; G Confalonieri; A Bonfanti
Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic disease.
The International journal of biological markers 1998;13(3):154-7.
1998: Paolo Lissoni; Franco Rovelli; Gabriele Fumagalli; G Confalonieri; Fernando Brivio; M Mariani
[Pharmacokinetics of melatonin].
Recenti progressi in medicina 1998;89(7-8):381-2.
1998: Paolo Lissoni; Luca Fumagalli; Franco Rovelli; Fernando Brivio; G Di Felice; F Majorca
In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.
British journal of cancer 1998;77(11):1957-60.
1998: Paolo Lissoni; Luca Fumagalli; Luisa Giani; Franco Rovelli; G Confalonieri; S Pescia
Vascular endothelial growth factor (VEGF) serum levels during cancer immunotherapy with IL-2: preliminary considerations.
The International journal of biological markers 1998;13(2):98-101.
1998: Paolo Lissoni; Franco Rovelli; Luisa Giani; C Gavazzeni; M Grazia Roselli; E Mainini; C Mazzi
Endocrine effects of two pineal hormones other than melatonin in healthy volunteers: 5-methoxytryptophol and 5-methoxytryptamine.
Recenti progressi in medicina 1998;89(4):183-5.
1998: Paolo Lissoni; Franco Rovelli; Luisa Giani; Luca Fumagalli; Mario Mandalà
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
Natural immunity 1998;16(5-6):178-84.
1998: Paolo Lissoni; Luisa Giani; S Zerbini; P Trabattoni; Franco Rovelli
Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.
Natural immunity 1998;16(1):27-33.
1998: Paolo Lissoni; Franco Rovelli; Fernando Brivio; O Brivio; Luca Fumagalli
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans.
Natural immunity 1998;16(1):1-5.
1998: Paolo Lissoni; Susan Mengo; Mario Mandalà; E Mauri; Fernando Brivio; Franco Rovelli; G Confalonieri; R Longarini; A Bonfante; D Folli; S Meregalli; S Barni; Gabriele Tancini; Luisa Giani
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy.
Journal of biological regulators and homeostatic agents 1998;12(1-2):38-41.
1997: Paolo Lissoni; Franco Rovelli; S Meregalli; Luca Fumagalli; Flavia Musco; Fernando Brivio; O Brivio; G Esposti
Melatonin as a new possible anti-inflammatory agent.
Journal of biological regulators and homeostatic agents 1997;11(4):157-9.
1997: Paolo Lissoni; Franco Rovelli; M R Rivolta; C Frigerio; Mario Mandalà; S Barni; Antonio Ardizzoia; Fabio Malugani; Gabriele Tancini
Acute endocrine effects of interleukin-12 in cancer patients.
Journal of biological regulators and homeostatic agents 1997;11(4):154-6.
1997: Paolo Lissoni; Franco Rovelli; S Pittalis; M Casati; Maristella Perego; M G Grassi; Fernando Brivio; Luca Fumagalli
Interleukin-12 in early or advanced cancer patients.
European journal of cancer (Oxford, England : 1990) 1997;33(10):1703-5.
1997: Paolo Lissoni; Luca Fumagalli; F Paolorossi; Franco Rovelli; maria grazia roselli; Georges Maestroni
Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
Journal of biological regulators and homeostatic agents 1997;11(3):119-22.
1997: Paolo Lissoni; Franco Rovelli; L Fumagalli; E Mauri; S Barni; Gabriele Tancini
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observations.
The International journal of biological markers 1997;12(3):125-7.
1996: Paolo Lissoni; Franco Rovelli; Luisa Giani; Luca Fumagalli; S Meregalli; G Comi; D Merlini
Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretion.
Journal of biological regulators and homeostatic agents 1996;10(4):92-4.
1996: Paolo Lissoni; Fernando Brivio; S Pittalis; Franco Rovelli; R Rescaldani; Maristella Perego; M G Grassi; S Barni; Gabriele Tancini; F Majorca; Luca Fumagalli
Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrations.
Journal of biological regulators and homeostatic agents 1996;10(2-3):60-2.
1996: Paolo Lissoni; S Pittalis; Franco Rovelli; S Zecchini; M Casati; M Tremolada; F Pelizzoni
Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol.
Journal of biological regulators and homeostatic agents 1996;10(1):27-30.
1996: Paolo Lissoni; S Pittalis; maria grazia roselli; Franco Rovelli; M G Viganò
Comparison between interleukin-2 and interleukin-12: effects on monocyte functions and their possible importance in the clinical significance of neopterin.
The International journal of biological markers 1996;11(1):58-9.
1995: Paolo Lissoni; S Barni; M Cazzaniga; Antonio Ardizzoia; Franco Rovelli; Gabriele Tancini; Fernando Brivio; F Frigerio
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
Oncology 1995;52(6):439-42.
1995: Paolo Lissoni; L Vigorè; R Rescaldani; Franco Rovelli; Fernando Brivio; Luisa Giani; S Barni; Gabriele Tancini; Antonio Ardizzoia; M G Viganò
Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study.
Journal of biological regulators and homeostatic agents 1995;9(4):155-8.
1995: Paolo Lissoni; Franco Rovelli; E Tisi; Fernando Brivio; Antonio Ardizzoia; S Barni; Gabriele Tancini; M Saudelli; E Cesana; M G Viganò
Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors.
Journal of biological regulators and homeostatic agents 1995;9(4):146-9.
1995: Barbara Zubelewicz; Ryszard Braczkowski; Franco Rovelli; Paolo Lissoni; S Pittalis
Stimulation of soluble interleukin-2 release by tumor necrosis factor-alpha in cancer patients.
The International journal of biological markers 1995;10(3):186-7.
1995: Paolo Lissoni; S Pittalis; Franco Rovelli; L Vigorè; maria grazia roselli; Fernando Brivio
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer.
Journal of biological regulators and homeostatic agents 1995;9(2):63-6.
1994: Paolo Lissoni; S Barni; M Cazzaniga; Antonio Ardizzoia; Franco Rovelli; Fernando Brivio; Gabriele Tancini
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone.
Oncology 1994;51(4):344-7.
1994: S Barni; Paolo Lissoni; Fernando Brivio; Luca Fumagalli; D Merlini; M Cataldo; Franco Rovelli; Gabriele Tancini
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin.
Tumori 1994;80(3):212-5.
1994: Paolo Lissoni; S Barni; Gabriele Tancini; Antonio Ardizzoia; G Ricci; R Aldeghi; Fernando Brivio; E Tisi; Franco Rovelli; R Rescaldani
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
British journal of cancer 1994;69(1):196-9.
1993: Paolo Lissoni; S Barni; Gabriele Tancini; Franco Rovelli; Antonio Ardizzoia; A Conti; G J Maestroni
A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients.
Oncology 1993;50(6):399-402.
1993: S Crispino; Paolo Lissoni; Antonio Ardizzoia; Franco Rovelli; Maristella Perego; M G Grassi; S Barni; S Pittalis; Gabriele Tancini
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Journal of biological regulators and homeostatic agents 1993;7(3):92-4.
1993: Paolo Lissoni; S Barni; Gabriele Tancini; Antonio Ardizzoia; Franco Rovelli; M Cazzaniga; Fernando Brivio; A Piperno; R Aldeghi; D Fossati
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
British journal of cancer 1993;67(6):1404-7.
1993: Fernando Brivio; Paolo Lissoni; R Redaelli; A Maggioni; Franco Rovelli; R Rescaldani; F Borin; L Erba; G Alderi
Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma.
Minerva chirurgica 1993;48(7):331-5.
1993: Paolo Lissoni; S Pittalis; Fernando Brivio; E Tisi; Franco Rovelli; Antonio Ardizzoia; S Barni; Gabriele Tancini; G Giudici; A Biondi
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2.
Cancer 1993;71(6):2076-81.
1993: Paolo Lissoni; S Barni; Franco Rovelli; Fernando Brivio; Antonio Ardizzoia; Gabriele Tancini; A Conti; G J Maestroni
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):185-9.
1993: Paolo Lissoni; S Barni; E Tisi; Franco Rovelli; S Pittalis; R Rescaldani; L Vigoré; A Biondi; Antonio Ardizzoia; Gabriele Tancini
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1127-32.
1992: Paolo Lissoni; Franco Rovelli; S Barni; Antonio Ardizzoia; S Pittalis; E Tisi; V Perlangeli; Gabriele Tancini
Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients.
Biological chemistry Hoppe-Seyler 1992;373(12):1217-22.
1992: Paolo Lissoni; E Mainini; Franco Rovelli; C Mazzi; Antonio Ardizzoia; Marco Gelosa; M Capra; M R Rivolta
A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours.
The European journal of medicine 1992;1(7):407-10.
1992: Paolo Lissoni; Franco Rovelli; Gabriele Tancini; E Tisi; M R Rivolta; Antonio Ardizzoia; Fernando Brivio
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancer.
Journal of biological regulators and homeostatic agents 1992;6(4):113-5.
1992: Paolo Lissoni; Franco Rovelli; E Tisi; D Ballabio; C Benenti; Antonio Ardizzoia; S Barni; B Tancini
Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patients.
The International journal of biological markers 1992;7(4):260-2.
1992: Paolo Lissoni; Franco Rovelli; E Tisi; Antonio Ardizzoia; V Perlangeli; S Barni; Gabriele Tancini
Endocrine effects of human recombinant interleukin-3 in cancer patients.
The International journal of biological markers 1992;7(4):230-3.
1992: S Crispino; Paolo Lissoni; Antonio Ardizzoia; S Barni; Franco Rovelli; Gabriele Tancini
Effects of granulocyte-macrophage colony stimulating factor on cortisol, growth hormone, prolactin and melatonin in cancer patients (short communication).
Journal of biological regulators and homeostatic agents 1992;6(4):142-4.
1992: Paolo Lissoni; E Tisi; S Barni; Antonio Ardizzoia; Franco Rovelli; R Rescaldani; D Ballabio; C Benenti; M Angeli; Gabriele Tancini
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
British journal of cancer 1992;66(1):155-8.
1991: Paolo Lissoni; S Barni; Franco Rovelli; S Crispino; Gabriele Fumagalli; S Pescia; M Vaghi; G Camesasca; Gabriele Tancini
Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patients.
Tumori 1991;77(3):212-5.
1991: Paolo Lissoni; S Barni; Franco Rovelli; Gabriele Tancini
Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report.
Oncology 1991;48(2):125-7.
1991: Paolo Lissoni; E Tisi; Fernando Brivio; S Barni; Franco Rovelli; M Perego; Gabriele Tancini
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.
European journal of cancer (Oxford, England : 1990) 1991;27(8):1014-6.
1990: Paolo Lissoni; Gabriele Tancini; Franco Rovelli; G Cattaneo; C Archili; S Barni
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
British journal of cancer 1990;62(5):838-9.
1990: Paolo Lissoni; S Barni; C Archili; G Cattaneo; Franco Rovelli; A Conti; G J Maestroni; Gabriele Tancini
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer.
Anticancer research 1990;10(3):753-7.
1990: Paolo Lissoni; S Barni; Franco Rovelli; R Rescaldani; V Rizzo; A Biondi; Gabriele Tancini
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patients.
Tumori 1990;76(1):14-7.
1990: C Archili; Paolo Lissoni; G Cattaneo; Franco Rovelli; Fernando Brivio; Gabriele Tancini; S Barni
Lack of changes in soluble interleukin-2 receptor serum levels during chemotherapy-induced lymphocyte damage.
The International journal of biological markers 1990;5(1):43-5.
1990: Paolo Lissoni; S Barni; Franco Rovelli; Simonetta Viviani; G J Maestroni; A Conti; Gabriele Tancini
The biological significance of soluble interleukin-2 receptors in solid tumors.
European journal of cancer (Oxford, England : 1990) 1990;26(1):33-6.
1989: Paolo Lissoni; S Barni; R Rescaldani; Franco Rovelli; Gabriele Tancini
Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
British journal of cancer 1989;60(4):616-7.
1989: Paolo Lissoni; V Rizzo; S Barni; R Rescaldani; Franco Rovelli; A Biondi; C Archili; F Frigerio; Gabriele Tancini
Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlated.
The International journal of biological markers 1989;4(3):170-3.
1989: Paolo Lissoni; S Barni; Gabriele Tancini; Simonetta Viviani; Franco Rovelli; R Rescaldani; G Fiorelli
Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
Journal of biological regulators and homeostatic agents 1989;3(3):131-3.
1989: Gabriele Tancini; Paolo Lissoni; S Barni; R Rescaldani; Franco Rovelli; A Sormani; S Crispino; T Saporito; E Tisi; C Benenti
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumors.
The International journal of biological markers 1989;4(2):123-4.
1988: Franco Rovelli; Paolo Lissoni; S Crispino; S Barni; G Fumagalli; F Paolorossi; Gabriele Tancini
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary study.
Tumori 1988;74(6):633-7.
1988: D Esposti; Paolo Lissoni; Gabriele Tancini; S Barni; S Crispino; F Paolorossi; Franco Rovelli; L Ferri; G Cattaneo; G Esposti
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerations.
Cancer 1988;62(3):494-9.
1988: S Barni; Paolo Lissoni; S Crispino; Franco Rovelli; G Esposti; Franco Fraschini; Gabriele Tancini
Serum levels of melatonin in cancer patients and their relation to body sizes.
The International journal of biological markers 1988;3(3):193-6.
1988: Paolo Lissoni; Gabriele Tancini; S Barni; S Crispino; F Paolorossi; Franco Rovelli; G Cattaneo; Franco Fraschini
Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patients.
Tumori 1988;74(3):339-45.
1988: S Barni; Paolo Lissoni; Franco Rovelli; S Crispino; F Paolorossi; D Esposti; G Esposti; Franco Fraschini; Gabriele Tancini
Alteration of opioid peptide circadian rhythm in cancer patients.
Tumori 1988;74(3):357-60.
1988: S Barni; Paolo Lissoni; S Crispino; G Cattaneo; Franco Rovelli; G Fumagalli; Gabriele Tancini
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratio.
The International journal of biological markers 1988;3(2):82-6.
1988: D Esposti; Paolo Lissoni; R Mauri; Franco Rovelli; L Orsenigo; S Pescia; G Vegetti; G Esposti; Franco Fraschini
The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.
Journal of endocrinological investigation 1988;11(2):103-6.
1987: Paolo Lissoni; S Barni; F Paolorossi; S Crispino; Franco Rovelli; L Ferri; G Delitala; Gabriele Tancini
Evidence for altered opioid activity in patients with cancer.
British journal of cancer 1987;56(6):834-7.
1987: S Barni; Paolo Lissoni; F Paolorossi; S Crispino; Franco Rovelli; L Ferri; A Sormani; U D'Alonso; A Bugatti; V Nociti
Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
European journal of cancer & clinical oncology 1987;23(8):1141-5.
1987: Paolo Lissoni; A Bastone; R Sala; R Mauri; Franco Rovelli; Simonetta Viviani; E Bajetta; D Esposti; G Esposti; L di Bella
The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels.
European journal of cancer & clinical oncology 1987;23(7):949-57.
1987: Paolo Lissoni; F Paolorossi; S Barni; Gabriele Tancini; S Crispino; Franco Rovelli; L Ferri; G Esposti; D Esposti; Franco Fraschini
Correlation between changes in prolactin and melatonin serum levels after radical mastectomy.
Tumori 1987;73(3):263-7.
1987: S Barni; Paolo Lissoni; Gabriele Tancini; S Crispino; F Paolorossi; Franco Rovelli; G Fumagalli; L Ferri; D Esposti; G Esposti
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patients.
Tumori 1987;73(2):181-5.
1986: S Barni; Paolo Lissoni; Gabriele Tancini; S Crispino; F Paolorossi; Franco Rovelli; G Fumagalli; L Ferri
Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancer.
Tumori 1986;72(4):399-403.